NutriBand (NTRB) Exchange Rate Effect (2016 - 2019)

NutriBand (NTRB) posted Exchange Rate Effect of -$252.0 for Q2 2019, down 4100.0% sequentially from -$6.0 in Q1 2019.

NutriBand (NTRB) Exchange Rate Effect (2016 - 2019) Analysis & Trends

NutriBand has reported Exchange Rate Effect for 4 years, with the latest figure at -$252.0 in Q2 2019.

Quarterly Exchange Rate Effect changed N/A year-over-year to -$252.0 in Q2 2019, while the trailing twelve-month figure through Jan 2020 was -$252.0 (down 145.08% YoY) and the FY2020 annual result came in at -$252.0, down 163.96% from the prior year.
Exchange Rate Effect fell to -$252.0 in Q2 2019 per NTRB's latest filing, from -$6.0 in the prior quarter.
Over five years, Exchange Rate Effect peaked at $531.0 in Q1 2018 and troughed at -$252.0 in Q2 2019.
A 4-year average of $39.33 and a median of $5.0 in 2016 frame the typical range for Exchange Rate Effect.
The widest YoY moves for Exchange Rate Effect: up 1670.0% in 2018, down 115.0% in 2018.
Over 4 years, Exchange Rate Effect stood at $11.0 in 2016, then soared by 263.64% to $40.0 in 2017, then tumbled by 115.0% to -$6.0 in 2018, then tumbled by 4100.0% to -$252.0 in 2019.
According to Business Quant data, Exchange Rate Effect over the past three periods registered -$252.0, -$6.0, and -$6.0 for Q2 2019, Q1 2019, and Q4 2018 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Exchange Rate Effect (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-3.70 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-300,000.00
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-2.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	19.84 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-2.45 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-287,000.00
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	1.63 Mn
10	NutriBand	46.38 Mn	42.37 Mn	196,801.00	-

Download Data